Adenocarcinomas at the gastroesophageal junction appear to arise from foci
of intestinal metaplasia that develop either in the distal esophagus or the
proximal stomach (the gastric cardia). Metaplasia is usually a consequence
of chronic inflammation, and it is logical to assume that intestinal metap
lasia at the gastroesophageal junction develops as a result of chronic infl
ammation in the epithelia that normally line the junction region. Intestina
l metaplasia in the esophagus is known to be a sequela of chronic inflammat
ion in squamous epithelium caused by gastroesophageal reflux disease, where
as intestinal metaplasia in the distal stomach is often a consequence of ch
ronic gastritis caused by Helicobacter pylori infection. For the gastric ca
rdia, the contributions of gastroesophageal reflux disease, H. pylori infec
tion, and other factors to inflammation, metaplasia, and neoplasia are not
clear. If physicians are to develop meaningful preventive strategies and sp
ecific therapies for tumors of the proximal stomach, a clear understanding
of pathogenesis is important. Recent studies on pathogenetic factors for in
flammation in cardiac epithelium (gastric carditis) have yielded contradict
ory results, perhaps because of fundamental differences in the techniques u
sed by different investigators for identifying and sampling the gastric car
dia. This report explores the roots of the controversy regarding the role o
f gastric carditis in the development of metaplasia and neoplasia at the ga
stroesophageal junction and suggests practical guidelines for biopsy protoc
ols to be used in future studies that will be necessary to resolve these di
sputes.